BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Liu Q, Qian MC, Liu ZF, Dong F, Liu DT, Li ML, Ning YP, Wang XP, Liu TB, Wu Q, Li T, Yu X. Safety and efficacy of different initial doses of lurasidone in the schizophrenia treatment: A multi-center, randomized, open-label study. World J Psychiatry 2025; 15(10): 110968 [PMID: 41112599 DOI: 10.5498/wjp.v15.i10.110968]
URL: https://www.wjgnet.com/2220-3206/full/v15/i10/110968.htm
Number Citing Articles
1
Tao Liu, Yang Liu. Initial lurasidone dosing in acute schizophrenia: Pragmatic and trajectory-aware clinical implicationsWorld Journal of Psychiatry 2026; 16(1): 113548 doi: 10.5498/wjp.v16.i1.113548
2
Juan Yan, Hao-Yu Xing. Critical commentary on initial lurasidone dosing strategies in acute schizophreniaWorld Journal of Psychiatry 2026; 16(3): 114882 doi: 10.5498/wjp.v16.i3.114882